Recent Updates
Recently added Catalysts
GNLX Positive Sentiment Score: 70/100

Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright

Friday, December 13, 2024 1 min read
Key Takeaway: Genelux Corporation (NASDAQ: GNLX) will have its President and CEO, Thomas Zindrick, participate in a virtual fireside chat with H.C. Wainwright & Co. on December 16, 2024. This session will explore the company's clinical programs, including trials for its lead candidate, Olvi-Vec, across multiple cancer types. The event signifies Genelux's efforts to keep investors informed regarding its ongoing research and development initiatives.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a fireside chat indicates engagement with investors.
  • Focus on clinical programs shows commitment to developmental progress.
  • Live discussion will provide insights into lead candidate and ongoing trials.

Full Press Release Details

WESTLAKE VILLAGE, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board will participate in a virtual fireside chat with H.C. Wainwright & Co. on December 16, 2024.
Biotech Equity Research Analyst, Emily Bodnar, will moderate the HCW@Home session which is scheduled to begin at 11:00 a.m. ET. The discussion will focus on the company’s clinical program of its lead candidate, Olvi-Vec, including its ongoing Phase 3 registration trial in platinum resistant/refractory ovarian cancer (PRROC), Phase 1b/2 trial in small-cell lung cancer (SCLC) and Phase 2 trial in non-small cell lung cancer (NSCLC). To join, please register at https://ct.to/n900Z9K. An archived replay will be available for approximately 90 days following the event on the company’s IR page.
About Genelux Corporation
Investor and Media Contacts
Allele Communications, LLC
genelux@allelecomms.com
Source: Genelux Corporation

Tags

Frequently Asked Questions

When will the Genelux virtual fireside chat take place?

The virtual fireside chat will happen on December 16, 2024, at 11:00 a.m. ET.

Who is moderating the Genelux chat with H.C. Wainwright?

Emily Bodnar, a biotech equity research analyst, will moderate the session.

What is the focus of the Genelux virtual chat?

The discussion will center on Genelux's clinical program, including its lead candidate, Olvi-Vec.

How can I join the Genelux virtual chat?

You can register to join at https://ct.to/n900Z9K.

Will there be a replay of the Genelux chat?

Yes, an archived replay will be available for about 90 days on the company’s IR page.

Tags: GNLX Viatris Investor Conferences Healthcare Genelux Corporation immuno-oncology clinical trials cancer research
Last updated: Dec 13, 2024